TRPM7 and cancer: On one hand, TRPM7 overexpression enhances cancer cell migration via myosin II-based contractility (Middelbeek et al., 2012; Meng et al., 2013), however, TRPM7 downregulation is required during intravasation to de-sensitize cells to shear stress (Yankaskas et al., 2021).